Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoantibodies in scleroderma

M J Fritzler1

  • 1Faculty of Medicine, McCaig Center for Joint Injury and Arthritis Research, University of Calgary, Canada.

The Journal of Dermatology
|May 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anti-synthetase syndrome occurring after SARS-CoV-2 infection.

Scandinavian journal of rheumatology·2022
Same author

An evidence-based strategy to screen for pulmonary arterial hypertension in systemic sclerosis.

Seminars in arthritis and rheumatism·2020
Same author

Autoantibodies in SLE: prediction and the <i>p</i> value matrix.

Lupus·2019
Same author

Describing and expanding the clinical phenotype of anti-MDA5-associated rapidly progressive interstitial lung disease: case series of nine Canadian patients and literature review.

Scandinavian journal of rheumatology·2017
Same author

The prevalence and determinants of anti-DFS70 autoantibodies in an international inception cohort of systemic lupus erythematosus patients.

Lupus·2017
Same author

Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: clinical associations.

Medicine·2016
Same journal

Achieving Targeted Combined Endpoints in Patients With Atopic Dermatitis: A Real-World Study.

The Journal of dermatology·2026
Same journal

Plasma Cell Balanitis-Like Penile Lesion as a Rare Manifestation of IgG4-Related Disease.

The Journal of dermatology·2026
Same journal

MRI-Based Surgical Margin Assessment in Dermatofibrosarcoma Protuberans: Correlation With Pathological Extent.

The Journal of dermatology·2026
Same journal

Risk Factors for Cutaneous Immune-Related Adverse Events in the Japanese Population: A Retrospective Single-Center Cohort Study.

The Journal of dermatology·2026
Same journal

Characterization of Prurigo Nodules in Adults With Moderate-To-Severe Atopic Dermatitis in Japan: A 2-Year Observational Study.

The Journal of dermatology·2026
Same journal

Real-World Effectiveness of Tildrakizumab in Japanese Patients With Psoriasis: Analyses Stratified by Prior Systemic Therapy, Maintenance of Early Responses, and Achievement of Delayed Responses.

The Journal of dermatology·2026
See all related articles

Scleroderma patients frequently have anti-nuclear antibodies (ANA) targeting various intracellular components. These autoantibodies are crucial for diagnosing scleroderma and may soon monitor treatment response.

Area of Science:

  • Immunology
  • Rheumatology
  • Autoimmunity

Background:

  • Scleroderma is characterized by autoantibodies against nuclear, nucleolar, and cytoplasmic components.
  • Early anti-nuclear antibody (ANA) detection in scleroderma was around 50% using rodent tissues.
  • Modern cell culture methods reveal ANA in up to 98% of scleroderma patients.

Purpose of the Study:

  • To investigate the spectrum of autoantibodies in scleroderma.
  • To highlight the diagnostic and prognostic significance of these autoantibodies.
  • To explore future applications of autoantibody testing in scleroderma management.

Main Methods:

  • Utilized cryopreserved rodent organ sections and tissue culture cell substrates for autoantibody detection.
  • Employed molecular and immunochemical techniques to identify specific intracellular autoantigens.

Related Experiment Videos

  • Conducted clinical studies correlating autoantibody presence with disease status.

    • Main Results:

    • ANA prevalence in scleroderma increased from 50% to 98% with improved detection methods.
    • Over 20 distinct intracellular autoantigens have been identified as targets in scleroderma sera.
    • Specific autoantibody profiles correlate with diagnostic and prognostic indicators in scleroderma.

    Conclusions:

    • Autoantibodies are highly prevalent in scleroderma, with increasing detection rates using advanced techniques.
    • Identified autoantibodies serve as vital diagnostic and prognostic biomarkers for scleroderma.
    • Future applications may include monitoring patient response to immunotherapies through autoantibody analysis.